| 1 |
Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era |
|
|
| Jacques Fantini, Fodil Azzaz, Henri Chahinian, Nouara Yahi |
|
| Viruses. 2023; 15(2): 284 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey |
|
|
| Estefanía Calvo-Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante, Serena Delbue |
|
| Microorganisms. 2022; 10(7): 1284 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Ivermectin for preventing and treating COVID-19 |
|
|
| Maria Popp, Stefanie Reis, Selina Schießer, Renate Ilona Hausinger, Miriam Stegemann, Maria-Inti Metzendorf, Peter Kranke, Patrick Meybohm, Nicole Skoetz, Stephanie Weibel |
|
| Cochrane Database of Systematic Reviews. 2022; 2022(6) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Ivermectin-Induced Clinical Improvement and Alleviation of Significant Symptoms of COVID-19 Outpatients: A Cross-Sectional Study |
|
|
| Morteza Shakhsi Niaee, Leila Zolghadr, Zahra Hosseinkhani, Peyman Namdar, Abbas Allami, Fatemeh Amini, Mehran Varnaseri, Allieh Pourdast, Nematollah Gheibi |
|
| Iranian Journal of Science and Technology, Transactions A: Science. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19 |
|
|
| Vicente Amirpasha Tirado-Kulieva, Ernesto Hernández-Martínez, Tania Jakeline Choque Rivera |
|
| Heliyon. 2022; : e10702 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19) |
|
|
| Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Lindsey R Baden, Vincent Chi-Chung Cheng, Kathryn M Edwards, Jason C Gallagher, Rajesh T Gandhi, William J Muller, Mari M Nakamura, John C O’Horo, Robert W Shafer, Shmuel Shoham, M Hassan Murad, Reem A Mustafa, Shahnaz Sultan, Yngve Falck-Ytter |
|
| Clinical Infectious Diseases. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021 |
|
|
| Martin Ho, Mina Tadrous, Anita Iacono, Katie Suda, Tara Gomes |
|
| Journal of Antimicrobial Chemotherapy. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud |
|
|
| Andrew Hill, Manya Mirchandani, Victoria Pilkington |
|
| Open Forum Infectious Diseases. 2022; 9(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 |
|
|
| Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck |
|
| American Journal of Therapeutics. 2022; 29(1): e87 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Re: “Commentary” by Rothrock et al. “Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19” |
|
|
| Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell |
|
| American Journal of Therapeutics. 2022; 29(2): e233 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 |
|
|
| Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck |
|
| American Journal of Therapeutics. 2022; 29(2): e237 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status |
|
|
| Nirmeen Sabry, Yasser Fouad, Mohamed AbdAllah, Ahmed Cordie, Gamal Esmat |
|
| American Journal of Therapeutics. 2022; Publish Ah |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232. |
|
|
| Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell |
|
| American Journal of Therapeutics. 2022; 29(4): 455 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype |
|
|
| Milena Soriano Marcolino, Karina Cardoso Meira, Nathalia Sernizon Guimarães, Paula Perdigão Motta, Victor Schulthais Chagas, Silvana Márcia Bruschi Kelles, Laura Caetano de Sá, Reginaldo Aparecido Valacio, Patrícia Klarmann Ziegelmann |
|
| BMC Infectious Diseases. 2022; 22(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients |
|
|
| Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari, Kyana Jafarabady, Sepehr Siahvoshi, Sayed-Hamidreza Mozhgani |
|
| Virology Journal. 2022; 19(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia |
|
|
| Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha |
|
| Current Drug Targets. 2022; 23(13): 1277 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials |
|
|
| Chenyang Zhang,Huaqing Jin,Yi Feng Wen,Guosheng Yin |
|
| Frontiers in Public Health. 2021; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Identification and Development of Therapeutics for COVID-19 |
|
|
| Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey M. Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, Jinhui Wang, Rishi Raj Goel, YoSon Park, Simina M. Boca, Anthony Gitter, Casey S. Greene, Jack A. Gilbert |
|
| mSystems. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Bayesian Hypothesis Testing and Hierarchical Modeling of Ivermectin Effectiveness |
|
|
| Martin Neil,Norman Fenton |
|
| American Journal of Therapeutics. 2021; 28(5): e576 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable |
|
|
| Jack M. Lawrence,Gideon Meyerowitz-Katz,James A. J. Heathers,Nicholas J. L. Brown,Kyle A. Sheldrick |
|
| Nature Medicine. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials |
|
|
| Abolfazl Akbari, Mahya Razmi, Alireza Sedaghat, Seyyed Mohammad Matin Alavi Dana, Mahdi Amiri, Ali Mohammad Halvani, Soroush Yazdani, Sajad Sahab-Negah |
|
| Expert Review of Anti-infective Therapy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
A Survey for Predictors of Mortality among COVID-19 Patients: A Retrospective Study from Iran |
|
|
| arezoo monfared, mohammad taghi moghadamnia, Samad Karkhah, saman maroufizadeh, Mohammad Asadian Rad, Jalal kheirkhah, fatemeh jafaraghayee |
|
| Jorjani Biomedicine Journal. 2021; 9(4): 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
